| Title |
Medical Marijuana and Chronic Pain: a Review of Basic Science and Clinical Evidence
|
|---|---|
| Published in |
Current Pain and Headache Reports, September 2015
|
| DOI | 10.1007/s11916-015-0524-x |
| Pubmed ID | |
| Authors |
Bjorn Jensen, Jeffrey Chen, Tim Furnish, Mark Wallace |
| Abstract |
Cannabinoid compounds include phytocannabinoids, endocannabinoids, and synthetics. The two primary phytocannabinoids are delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), with CB1 receptors in the brain and peripheral tissue and CB2 receptors in the immune and hematopoietic systems. The route of delivery of cannabis is important as the bioavailability and metabolism are very different for smoking versus oral/sublingual routes. Gold standard clinical trials are limited; however, some studies have thus far shown evidence to support the use of cannabinoids for some cancer, neuropathic, spasticity, acute pain, and chronic pain conditions. |
X Demographics
The data shown below were collected from the profiles of 14 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 5 | 36% |
| Spain | 2 | 14% |
| Unknown | 7 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 13 | 93% |
| Practitioners (doctors, other healthcare professionals) | 1 | 7% |
Mendeley readers
The data shown below were compiled from readership statistics for 401 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Italy | 1 | <1% |
| Canada | 1 | <1% |
| Denmark | 1 | <1% |
| Puerto Rico | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 396 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 65 | 16% |
| Researcher | 62 | 15% |
| Student > Master | 51 | 13% |
| Other | 42 | 10% |
| Student > Ph. D. Student | 36 | 9% |
| Other | 81 | 20% |
| Unknown | 64 | 16% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 128 | 32% |
| Pharmacology, Toxicology and Pharmaceutical Science | 34 | 8% |
| Nursing and Health Professions | 27 | 7% |
| Psychology | 24 | 6% |
| Agricultural and Biological Sciences | 20 | 5% |
| Other | 89 | 22% |
| Unknown | 79 | 20% |
Attention Score in Context
This research output has an Altmetric Attention Score of 62. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 April 2022.
All research outputs
#612,651
of 23,545,680 outputs
Outputs from Current Pain and Headache Reports
#20
of 812 outputs
Outputs of similar age
#8,635
of 268,227 outputs
Outputs of similar age from Current Pain and Headache Reports
#3
of 9 outputs
Altmetric has tracked 23,545,680 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 812 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.3. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 268,227 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 9 others from the same source and published within six weeks on either side of this one. This one has scored higher than 6 of them.